Research-context answer There is no approved missed-dose guidance
Recent studies indicate that by 2030, almost 14% of men and 20% of women around the globe are expected to experience obesity (Federation 2022)
The Metabolic Cost of Unplanned Interruptions Research indicates that even brief discontinuations can trigger rapid appetite rebound
If youre on Medicare or Medicaid and still determined to access tirzepatide without bankrupting yourself, here are the most realistic routes: Ask about patient assistance programs (PAPs): Some foundations and nonprofit organizations, like the PAN Foundation or Patient Advocate Foundation, offer grants for medications based on income
Rasmussen JC, Kwon S, Pinal A, Bareis A, Velasquez FC, Janssen CF, et al